Fingerprint
Dive into the research topics of 'Phase III, placebo-controlled trial of three doses of citalopram for the treatment of hot flashes: NCCTG trial N05C9'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase III, placebo-controlled trial of three doses of citalopram for the treatment of hot flashes: NCCTG trial N05C9
Debra L. Barton, Beth I. LaVasseur, Jeff A. Sloan, Allen N. Stawis, Kathleen A. Flynn, Missy Dyar, David B. Johnson, Pamela J. Atherton, Brent Diekmann, Charles L. Loprinzi
Research output: Contribution to journal › Article › peer-review
87
Scopus
citations